PDC*line Pharma
@pdc_line
Followers
241
Following
989
Media
115
Statuses
498
A biotechnology company developing a first in class Plasmacytoid Dendritic cell line, PDC*line providing unmatched advantages #immunooncology #neoantigen
Liege, Belgium
Joined December 2017
-> Don’t miss this article.
In this interview, Eric Halioua reflects on the start, success and momentum of PDC*line Pharma, a clinical-stage biotechnology company developing allogeneic cellular immunotherapies for cancer. He also shares three top tips for start-up companies on their investment and funding
0
0
0
RT @RegMedNet: In this interview, Eric Halioua reflects on the start, success and momentum of PDC*line Pharma, a clinical-stage biotechnolo….
0
2
0
RT @pdc_line: @pdc_line is excited to be part of the 25th #BioEquityEurope Presenting Company Class of 2025!.@EricHalioua , will be attendi….
0
1
0
RT @HaliouaEric: Excited to be part of the 25th #BioEquityEurope Presenting Company Class of 2025 next week in Bruges, Belgium!.This year’s….
0
2
0
@pdc_line is excited to be part of the 25th #BioEquityEurope Presenting Company Class of 2025!.@EricHalioua , will be attending the event next week in Bruges, Belgium .📅 Learn more: 📍 Organized by Informa Connect.We look forward to seeing you in Bruges!
0
1
2
RT @HaliouaEric: 🤝 Clap de fin pour le Festival #Imagésanté ! Toute l’équipe de @pdc_line Pharma est ravie d’avoir une nouvelle fois souten….
0
1
0
Exciting news! Our abstract has been accepted for a poster presentation at the European Lung Cancer Congress (ELCC) 2025. We’re proud to share new data from our ongoing clinical development program with PDC*lung01, our therapeutic cancer vaccine NSCLC.
0
1
2
Tomorrow’s the day! We’re excited to share that our CEO is speaking at Advanced Therapies UK 2025, where industry leaders will gather for 2 days of insightful discussions, networking, and innovation. There’s still time to join us in London!. #adtherapies
0
0
1
RT @HaliouaEric: I’m thrilled to be attending the J.P. Morgan Conference in San Francisco from Sunday to Wednesday evening. If you’re atten….
0
1
0
We are thrilled to be hosting an Executive Roundtable at.@WuXi_AppTec #WuXiGlobalForum during #JPM2025! I’m excited to discuss about opportunities of innovative cancer vaccines ! Learn more about the event here:
0
0
0
RT @GossetOlivier1: La société liégeoise PDC*line Pharma a enregistré de bons résultats cliniques en phase I/II avec son vaccin thérapeutiq….
0
2
0
RT @ALA_Group: [ALA Client News] @pdc_line Pharma presents primary clinical results from phase I/II trial on PDC*lung01 cancer vaccine at E….
0
1
0
RT @AKTforWallonia: #revuedepresse.💉Des résultats cliniques encourageants pour la biotech liégeoise @pdc_line pour son vaccin thérapeutique….
0
1
0
We are thrilled to share the primary clinical results from our Phase I/II trial of the PDC*lung01 cancer vaccine, presented at ESMO-IO 2024! PDC*lung01, combined with pembro, shows potential for meaningful clinical benefit compared to pembro alone in stage IV NSCLC patients.
1
0
1
RT @HaliouaEric: New Article Featuring CEO of @pdc_line Published in @BioprocessIC Interview provides valuable insights into the driving fo….
0
1
0